Advertisement
Screener

CRONOS GROUP INC. (CRON) Interest Expense

2.8 / 5 stars · 68/120 Roast Me

CRONOS GROUP INC. Interest Expense

CRONOS GROUP INC. (CRON) reported Interest Expense of $13.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-28.

Discontinued › Expense Statement › Interest Expense

us-gaap:InterestExpense · last filed 2023-02-28

  • CRONOS GROUP INC. interest expense for the quarter ending 2021-12-31 was $7.00K.
  • CRONOS GROUP INC. interest expense for the quarter ending 2021-09-30 was $7.00K, a 94.44% decline year-over-year.
  • CRONOS GROUP INC. interest expense for the quarter ending 2021-06-30 was $7.00K, a 91.57% decline year-over-year.
  • CRONOS GROUP INC. interest expense for the quarter ending 2021-03-31 was $6.00K, a 14.29% decline year-over-year.
  • CRONOS GROUP INC. interest expense for fiscal 2022 was $13.00K, a 51.85% decline from fiscal 2021.
  • CRONOS GROUP INC. interest expense for fiscal 2021 was $27.00K, a 85.48% decline from fiscal 2020.
  • CRONOS GROUP INC. interest expense for fiscal 2020 was $186.00K, a 85.05% decline from fiscal 2019.
  • CRONOS GROUP INC. interest expense for fiscal 2019 was $1.24M, a 794.96% increase from fiscal 2018.
Period endInterest Expense 3 monthInterest Expense 3 month as first filedInterest Expense 6 monthInterest Expense 9 monthInterest Expense 9 month as first filedInterest Expense 12 month
2022-12-31$13.00K
10-K · filed 2023-02-28
2021-12-31$7.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$14.00K
derived: sum of 2 quarters · filed 2023-02-28
$21.00K
derived: sum of 3 quarters · filed 2023-02-28
$27.00K
10-K · filed 2023-02-28
2021-09-30$7.00K
10-Q · filed 2022-02-18
$14.00K
derived: sum of 2 quarters · filed 2022-02-18
$20.00K
10-Q · filed 2022-02-18
-$10.00K
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30$7.00K
10-Q/A · filed 2022-02-18
$13.00K
10-Q/A · filed 2022-02-18
-$17.00K
derived: sum of 3 quarters · filed 2023-02-28
$109.00K
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31$6.00K
10-Q · filed 2021-05-07
-$24.00K
derived: sum of 2 quarters · filed 2023-02-28
$102.00K
derived: sum of 3 quarters · filed 2023-02-28
$185.00K
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31-$30.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$96.00K
derived: sum of 2 quarters · filed 2023-02-28
$179.00K
derived: sum of 3 quarters · filed 2023-02-28
$186.00K
10-K · filed 2023-02-28
2020-09-30$126.00K
10-Q · filed 2022-02-18
$66.00K
10-Q · filed 2020-11-05
$209.00K
derived: sum of 2 quarters · filed 2022-02-18
$216.00K
10-Q · filed 2022-02-18
$156.00K
10-Q · filed 2020-11-05
2020-06-30$83.00K
10-Q/A · filed 2022-02-18
$90.00K
10-Q/A · filed 2022-02-18
2020-03-31$7.00K
10-Q · filed 2021-05-07
2019-12-31$1.24M
10-K · filed 2022-03-01
2018-12-31$139.00K
10-K · filed 2021-02-26
2017-12-31$101.00K
10-K/A · filed 2020-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87